Akero Therapeutics (AKRO) News Today

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

$20.51

-1.09 (-5.05%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Short Interest in Akero Therapeutics, Inc. (NASDAQ:AKRO) Drops By 17.2% marketbeat.com - April 13 at 10:59 AM
	Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings stockhouse.com - April 7 at 8:24 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO prnewswire.com - April 4 at 7:25 PM
	Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Jonathan Young Sells 5,000 Shares insidertrades.com - April 4 at 6:41 AM
	Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells 5,000 Shares of Stock marketbeat.com - April 3 at 9:42 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO stockhouse.com - April 3 at 6:39 PM
	Akero Therapeutics' EFX Data Warrants Caution seekingalpha.com - April 3 at 3:37 AM
	Ademi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc. prnewswire.com - April 2 at 6:05 PM
	Vanguard Group Inc. Purchases 326,308 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) marketbeat.com - April 2 at 4:10 AM
	4D Molecular slips after regulatory update on lead asset msn.com - March 28 at 12:34 PM
	Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Average Rating of "Buy" from Analysts marketbeat.com - March 26 at 4:44 AM
	Akero Therapeutics, Inc. (NASDAQ:AKRO) Holdings Trimmed by Deutsche Bank AG marketbeat.com - March 22 at 4:16 AM
	Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Holdings Trimmed by Wellington Management Group LLP marketbeat.com - March 21 at 4:14 AM
	Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 3% marketbeat.com - March 20 at 1:51 PM
	Akero Therapeutics (NASDAQ:AKRO) Shares Gap Down to $27.54 marketbeat.com - March 18 at 11:25 AM
	Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That finance.yahoo.com - March 18 at 8:58 AM
	Akero Therapeutics CSO sells shares worth over $17k investing.com - March 17 at 10:44 AM
	Akero Therapeutics CFO sells shares to cover tax withholding investing.com - March 17 at 10:44 AM
	AKRO Apr 2024 42.500 call finance.yahoo.com - March 16 at 6:41 PM
	Catriona Yale Sells 20,646 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock insidertrades.com - March 16 at 8:43 AM
	Madrigal’s stock surges as FDA approves first drug for liver disease MASH msn.com - March 16 at 1:40 AM
	Madrigal climbs amid hopes for new NASH drug; B. Riley upgrades msn.com - March 15 at 8:40 AM
	Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 6.8% marketbeat.com - March 14 at 12:47 PM
	AKRO Aug 2024 30.000 put finance.yahoo.com - March 10 at 8:48 AM
	AKRO Aug 2024 17.500 put finance.yahoo.com - March 9 at 9:13 AM
	Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Northern Trust Corp marketbeat.com - March 9 at 4:50 AM
	Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares globenewswire.com - March 8 at 4:02 PM
	Akero Therapeutics’ Strong Trial Results and Market Positioning Justify Buy Rating markets.businessinsider.com - March 8 at 2:36 PM
	AKRO Jan 2025 2.500 call finance.yahoo.com - March 8 at 9:36 AM
	Analysts Offer Predictions for Akero Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:AKRO) marketbeat.com - March 8 at 7:21 AM
	Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology globenewswire.com - March 7 at 4:01 PM
	President and CEO Andrew Cheng Sells 75,000 Shares of Akero Therapeutics Inc (AKRO) finance.yahoo.com - March 7 at 8:07 AM
	Akero's fatty liver disease drug lessens scarring in mid-stage trial msn.com - March 6 at 5:48 PM
	Akero Therapeutics announces pricing of stock offering to raise $319M msn.com - March 6 at 5:48 PM
	Akero Therapeutics Announces Pricing of Public Offering of Common Stock globenewswire.com - March 5 at 9:13 PM
	Akero Therapeutics (NASDAQ:AKRO) Trading Down 7.2% marketbeat.com - March 5 at 3:18 PM
	UBS Group Increases Akero Therapeutics (NASDAQ:AKRO) Price Target to $42.00 marketbeat.com - March 5 at 10:46 AM
	Akero Therapeutics Commences Public Offering Of $300 Mln Of Shares markets.businessinsider.com - March 5 at 1:39 AM
	Akero Therapeutics price target raised by $14 at Evercore ISI, here's why realmoney.thestreet.com - March 4 at 8:39 PM
	Akero Therapeutics: Promising Phase IIb Results Propel Strong Buy Rating markets.businessinsider.com - March 4 at 8:39 PM
	Akero Therapeutics Announces Proposed Public Offering of Common Stock globenewswire.com - March 4 at 4:21 PM
	Akero Therapeutics' Stock Is Soaring Monday - Here's Why msn.com - March 4 at 3:39 PM
	Why Akero Rocketed — And Rival 89bio Topped It — On Results In Liver Disease Treatment finance.yahoo.com - March 4 at 3:39 PM
	Data Suggests Makers of Fatty Liver Treatments Won’t Be Displaced by Obesity Drugs finance.yahoo.com - March 4 at 3:39 PM
	Adage Capital Partners GP L.L.C. Lowers Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) marketbeat.com - March 4 at 10:45 AM
	Akero Therapeutics Inc.: Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study finanznachrichten.de - March 4 at 10:38 AM
	Akero stock jumps as lead drug shows added fibrosis improvement in MASH patients msn.com - March 4 at 10:38 AM
	UPDATE 1-Akero's lead drug helps reduce scarring in fatty liver disease patients finance.yahoo.com - March 4 at 10:38 AM
	Akero Rockets 27%, Prodding Rival 89bio Higher, On Promising Liver Disease Treatment finance.yahoo.com - March 4 at 10:38 AM
	Akero's lead drug helps improve scarring in fatty liver disease patients reuters.com - March 4 at 6:11 AM

Get Akero Therapeutics News Delivered to You Automatically

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

AKRO Media Mentions By Week

AKRO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AKRO
News Sentiment
▼
1.91

0.53
▲
Average
Medical
News Sentiment

AKRO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AKRO Articles
This Week
▼
1

4
▲
AKRO Articles
Average Week

Get Akero Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:AKRO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Akero Therapeutics (AKRO) News Today

AKRO Media Mentions By Week

AKRO Media Sentiment

AKRO News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info